William Fitzgerald Demas MD
Medical Director , Radiation Oncology,Seidman Cancer Center at Salem Regional Medical CenterHospital; Professor &Chair,Radiology ,NortheastOhio Medical University.
Join to view full profile
525 E Market StAkron, OH 44304
Phone+1 330-375-3557
Fax+1 337-376-1302
Dr. Demas is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. William Demas is a Radiation Oncologist based in Akron, OH, with a comprehensive background in radiation therapy techniques such as stereotactic radiosurgery and intensity-modulated radiation therapy. He completed his medical education at the State University of New York Downstate Medical Center College of Medicine followed by residencies at Maimonides Medical Center/SUNY Downstate and the University of Texas MD Anderson Cancer Center. Dr. Demas has contributed to several research publications involving treatments for cancer metastases and radiation therapy, which have been cited multiple times. Additionally, he has played roles in various clinical trials examining innovative therapies for breast, esophageal, kidney, and pancreatic cancers, as well as head and neck conditions.
Education & Training
University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 1985 - 1986
Maimonides Medical Center/SUNY Downstate HSUResidency, Radiation Oncology, 1981 - 1985
State University of New York Downstate Medical Center College of MedicineClass of 1981
Certifications & Licensure
CA State Medical License 1986 - 2028
TX State Medical License 1986 - 2028
NY State Medical License 1983 - 2027
OH State Medical License 1986 - 2027
American Board of Radiology Radiation Oncology
Clinical Trials
- Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer
- Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
- Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer Start of enrollment: 2005 Jul 26
Publications & Presentations
PubMed
- 11 citationsRandomized phase III trial to evaluate radiopharmaceuticals and zoledronic acid in the palliation of osteoblastic metastases from lung, breast, and prostate cancer: re...Michael J. Seider, Stephanie L. Pugh, Corey J. Langer, Gwen Wyatt, W. Demas
Annals of Nuclear Medicine. 2018-08-09 - 39 citationsMinimal clinically important differences in the EORTC QLQ-C30 and brief pain inventory in patients undergoing re-irradiation for painful bone metastases.Srinivas Raman, Keyue Ding, Edward Chow, Ralph M. Meyer, Yvette M. van der Linden
Quality of Life Research. 2018-04-01 - 1 citationsGender and age make no difference in the re-irradiation of painful bone metastases: A secondary analysis of the NCIC CTG SC.20 randomized trial.Ronald Chow, Keyue Ding, Vithusha Ganesh, Ralph M. Meyer, Yvette M. van der Linden
Radiotherapy and Oncology. 2017-11-05
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: